A-271 - RESCUE STUDY – International Survey on training of Dermatology Residents in Supportive Oncodermatology

Autor: Ortiz Brugués, A., Apalla, Z., Nikolaou, V., Freites-Martinez, A., Anadkat, M., Bang, A., Elshot, Y., Forsea, A.-M., Pagès, C., Guillon, B., Lacroix, N., Boileau, M., Fattore, D., Lacouture, M., Sibaud, V.

Publikováno v: In EJC Skin Cancer 2024 2 Supplement 1

Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases.

Autor: Ingen-Housz-Oro S; Dermatology Department, AP-HP, Henri Mondor Hospital.; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD group, Paris.; University Paris est Créteil EpidermE, Créteil, France.; EADV European Task Force 'Dermatology for cancer patients'.; ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris., Milpied B; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD group, Paris.; EADV European Task Force 'Dermatology for cancer patients'.; ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris.; Dermatology Department, CHU Bordeaux, Bordeaux., Bensaid B; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD group, Paris.; ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris.; Dermatology Department, CHU Edouard Herriot, Lyon, France., Elshot Y; EADV European Task Force 'Dermatology for cancer patients'.; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Brüggen MC; ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris.; Department of Dermatology, University Hospital Zurich.; Faculty of Medicine, University Zurich, Zurich.; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland., Starace M; EADV European Task Force 'Dermatology for cancer patients'.; Dermatology -IRCCS Policlinico di Sant'Orsola, Department of Experimental, Diagnostic and Specialty Medicine (DIMES) Alma Mater Studiorum University of Bologna, Italy., Kaffenberger BH; EADV European Task Force 'Dermatology for cancer patients'.; Dermatology Department, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Carrera C; EADV European Task Force 'Dermatology for cancer patients'.; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona.; CIBERER Centro de investigaciones Biomedicas en Red de Enfermedades Raras Insituto de Salud Carlos III.; Pharmacovigilance Technical Committee Hospital Clinic Barcelona., Pham-Ledard A; Dermatology Department, CHU Bordeaux, Bordeaux., Freites-Martinez A; EADV European Task Force 'Dermatology for cancer patients'.; Oncodermatology Clinic, Hospital Ruber Juan Bravo and Universidad Europea, Madrid, Spain., Sanchez-Pena P; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD group, Paris.; Pharmacovigilance Department, CHU Bordeaux, Bordeaux., Lebrun-Vignes B; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD group, Paris.; Pharmacovigilance Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France., French LE; ToxiTEN group, European Reference Network for Rare Skin Diseases, Paris.; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilan University (LMU) Munich, Munich, Germany.; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Sibaud V; EADV European Task Force 'Dermatology for cancer patients'.; Department of Oncodermatology, Claudius Regaud Institute and University Cancer Institute Toulouse Oncopole, Toulouse, France.

Publikováno v: Melanoma research [Melanoma Res] 2023 Apr 01; Vol. 33 (2), pp. 155-158. Date of Electronic Publication: 2023 Feb 06.

Mucocutane afwijkingen bij doelgerichte en immunotherapie

Autor: Elshot, Y. S., Tio, D., Crijns, M. B., Bekkenk, M. W.

Publikováno v: Nederlands tijdschrift voor dermatologie en venereologie, 29(3), 29-33. DCHG Partners in Mediscne Communicatie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::fe6c6a0db028c3a97f60f89cd0e47412
https://pure.amc.nl/en/publications/mucocutane-afwijkingen-bij-doelgerichte-en-immunotherapie(44398ab4-8a60-4ea2-bb6e-5c03080af773).html

Efficacité et sécurité du dupilumab dans la gestion des dermatoses prurigineuses développées sous inhibiteurs de checkpoint immunitaires

Autor: Giacchero, D., Apalla, Z., Passeron, T., Hirner, J., Rousset, J., Gérard, E., Lebbé, C., Gaide, O., Grafanaki, K., Nikolaou, V., Koumaki, D., Sollena, P., Carrera, C., Elshot, Y., Freites, A., Jimenez, A., Kraehenbuehl, L., Riganti, J., Starace, M., Sibaud, V.

Publikováno v: Annales de Dermatologie et de Vénéréologie - FMC; December 2024, Vol. 4 Issue: 8, Number 8 Supplement 1 pA56-A56, 1p

Het effect van melanotaninjecties op melanocytaire laesies

Autor: Van Der Poel, L. A.J., Elshot, Y. S., Van Der Kleij, S. M., Crijns, M. B.

Publikováno v: Van Der Poel, L A J, Elshot, Y S, Van Der Kleij, S M & Crijns, M B 2017, ' Het effect van melanotaninjecties op melanocytaire laesies ', Nederlands Tijdschrift voor Dermatologie en Venereologie, vol. 27, no. 3, pp. 115-117 .

We describe a case of a 34 year old female patient with eruptive naevi and an increase of pigmentation in existing naevi. In one of the naevi a diagnose of a MELTUMP was made. The patient had been receiving weekly injections of Melanotan, an syntheti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::8d1b4728917ca16fdd1ff4e4ac2b39ed
https://research.vumc.nl/en/publications/0fdf899f-e18a-40dd-9c6f-a4c0b79d30ae